Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Trabzuni, Daniah ^a,b   Ryten, Mina ^a   Emmett, Warren ^c   Ramasamy, Adaikalavan ^d   Lackner, Karl J ^e   Zeller, Tanja ^f   Walker, Robert ^g   Smith, Colin ^g   Lewis, Patrick A ^a,h   Mamais, Adamantios ^a,i   de Silva, Rohan ^a,i   Vandrovcova, Jana ^a,i   Hernandez, Dena ^j   Nalls, Michael A ^j   Sharma, Manu ^k   Garnier, Sophie ^l   Lesage, Suzanne ^l   Simon Sanchez, Javier ^m   Gasser, Thomas ^k   Heutink, Peter ^m   Brice, Alexis ^l   Singleton, Andrew ^j   Cai, Huaibin ^j   Schadt, Eric ⁿ   Wood, Nicholas W ^a   Bandopadhyay, Rina ^a,i   Weale, Michael E ^d   Hardy, John ^a,i   Plagnol, Vincent ^c   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^f UNIVERSITY HEART CENTER HAMBURG   (Germany)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF READING   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j NATIONAL INSTITUTE ON AGING   (United States)

^k UNIVERSITY OF TÜBINGEN   (Germany)

^l SORBONNE UNIVERSITÉ   (France)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; MESSENGER RNA;

ARTICLE; CASE CONTROL STUDY; CEREBELLUM; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; EXON; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEPROSY; LIVER; LRRK2 GENE; MAJOR CLINICAL STUDY; MONOCYTE; PARKINSON DISEASE; PUTAMEN; QUANTITATIVE TRAIT LOCUS; RNA SEQUENCE; RNA SPLICING; SUBSTANTIA NIGRA;

ALTERNATIVE SPLICING; BRAIN; CROHN DISEASE; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; LEPROSY; MALE; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; QUANTITATIVE TRAIT LOCI; RNA, MESSENGER;

EID: 84881484502     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070724     Document Type: Article

References (37)

1. Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, et al. (2011) Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet neurology 10: 898-908.
2. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet neurology 7: 583-590.
3. Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, et al. (2007) A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 147: 1047-1058.
4. Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377: 641-649.
5. Lewis PA, Manzoni C, (2012) LRRK2 and Human Disease: A Complicated Question or a Question of Complexes? Sci Signal 5: pe2.
6. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, et al. (2009) Genomewide association study of leprosy. N Engl J Med 361: 2609-2618.
7. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1125.
8. Cookson MR, (2010) The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Nat Rev Neurosci 11: 791-797.
9. West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, et al. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102: 16842-16847.
10. Lewis PA, Greggio E, Beilina A, Jain S, Baker A, et al. (2007) The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 357: 668-671.
11. Greggio E, Cookson MR (2009) Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro 1.
12. Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600.
13. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607.
14. Galter D, Westerlund M, Carmine A, Lindqvist E, Sydow O, et al. (2006) LRRK2 expression linked to dopamine-innervated areas. Annals of neurology 59: 714-719.
15. Higashi S, Biskup S, West AB, Trinkaus D, Dawson VL, et al. (2007) Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res 1155: 208-219.
16. Sharma S, Bandopadhyay R, Lashley T, Renton AE, Kingsbury AE, et al. (2011) LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study. Neuropathology and Applied Neurobiology 37: 777-790.
17. Vitte J, Traver S, Maues De Paula A, Lesage S, Rovelli G, et al. (2010) Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease. J Neuropathol Exp Neurol 69: 959-972.
18. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
19. Plagnol V, Smyth DJ, Todd JA, Clayton DG, (2009) Statistical independence of the colocalized association signals for type 1 diabetes and RPS26 gene expression on chromosome 12q13. Biostatistics 10: 327-334.
20. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis G, (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nature Genetics 44: 955-959.
21. Plagnol V, Nalls MA, Bras JM, Hernandez DG, Sharma M, et al. (2011) A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 7: e1002142.
22. Trabzuni D, Ryten M, Walker R, Smith C, Imran S, et al. (2011) Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. Journal of neurochemistry 119: 275-282.
23. Schadt EE, Molony C, Chudin E, Hao K, Yang X, et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS biology 6: e107.
24. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PloS one 5: e10693.
25. Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, et al. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29: 15-21.
26. Liu Z, Lee J, Krummey S, Lu W, Cai H, et al. (2011) The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol 12: 1063-1070.
27. Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, et al. (2012) MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Human molecular genetics 18: 4094-4103.
28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. American journal of human genetics 81: 559-575.
29. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR, (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816-834.
30. Li Y, Willer C, Sanna S, Abecasis G, (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10: 387-406.
31. Millar T, Walker R, Arango JC, Ironside JW, Harrison DJ, et al. (2007) Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol 213: 369-375.
32. Beach TG, Sue LI, Walker DG, Roher AE, Lue L, et al. (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 9: 229-245.
33. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
34. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
35. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, et al. (2007) Evidence based selection of housekeeping genes. PLoS One 2: e898.
36. Coulson DT, Brockbank S, Quinn JG, Murphy S, Ravid R, et al. (2008) Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol Biol 9: 46.
37. Chervoneva I, Li Y, Schulz S, Croker S, Wilson C, et al. (2010) Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics 11: 253.